Kang et al. also proposed that interventions including the intermittent hypoxia conditioning and hyperbaric oxygen therapy to elevate the level of HIF-1 in the brain might be considered as new additional treatments for depression (Kang et al. 2021). Here, HIF1A is linked to depressive symptom measurement.